{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Northvale",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78502",
      "recalling_firm": "Elite Laboratories Inc.",
      "address_1": "165 Ludlow Ave",
      "address_2": "N/A",
      "postal_code": "07647-2305",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "NY only",
      "recall_number": "D-0107-2018",
      "product_description": "Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only,  Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC  342806263013",
      "product_quantity": "1264 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20171113",
      "center_classification_date": "20171205",
      "termination_date": "20190315",
      "report_date": "20171213",
      "code_info": "Lot #: P0910-017, Exp. 05/2019",
      "more_code_info": ""
    }
  ]
}